COMMUNIQUÉS West-GlobeNewswire

AnewHealth and IntusCare Announce Advanced, Bidirectional Integration to Simplify Medication Management for PACE Programs
12/10/2026
The integration of AnewHealth's EireneRx® and IntusCare’s CareHub EMR, two platforms purpose-built for PACE, will connect participant and medication information to help create a more seamless experience for PACE care [...]
IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
12/10/2026
Photo: IM8 co-founder David Beckham; two-time NBA champion Chris Bosh; IM8 chief of staff and brand partnerships Samantha Kwok; and NBA executives (Credit: NBA) – IM8 will Host Fan Activation at an NBA House in the [...]
Aro Biotherapeutics Reports Therapeutic Potential of Centyrin – IFIH1 siRNA Conjugate for the Treatment of Type 1 Diabetes
12/10/2026
Oral presentation at the Breakthrough T1D Clinical & Research Congress highlights preclinical studies showing reduced blood glucose levels, delayed disease onset, and improved survival in a Type 1 diabetes mouse [...]
Ozari Health Expands Nationwide GLP-1 Telehealth Platform With Two Plans for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month
12/10/2026
LegitScript-certified platform now offers Ozari One, compounded semaglutide with B12 at $86 per month and tirzepatide with B12 at $125 per month, and Ozari Select, with a choice of formulation, billing term, and [...]
Baylor Genetics to Showcase How Genome Sequencing is Advancing Pediatric Care at the 2026 Child Neurology Society Annual Meeting
12/10/2026
HOUSTON, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will highlight the [...]
Waylo Ahead Launches Initiative for Young Drivers Beyond the Test
12/10/2026
SYDNEY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Waylo Ahead today announced the launch of a global road-safety initiative designed to help families close the gap between passing the driving test and being prepared to drive [...]
Alignment Health Launches New Medicare Advantage Plan Designed for Asian American Seniors in Los Angeles and Orange Counties
12/10/2026
New Central Health Harmony plan offers access to more than 600 Chinese-, Korean- and Vietnamese-speaking physicians, culturally tailored benefits and leading provider partners including Astrana Health ORANGE, Calif., [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
12/10/2026
COPENHAGEN, Denmark, October 12, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an amount [...]
MediciNova CEO Provides Shareholder Update
12/10/2026
LA JOLLA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
BSACI 2026: New preference and ease-of-use data comparing EURneffy® nasal adrenaline spray and adrenaline auto-injector trainer devices
12/10/2026
New UK comparative study data assessing patient preferences between trainer devices suggest EUR neffy ® is viewed as less burdensome than adrenaline auto-injectors (AAIs) 1 After trying both trainer devices, patients [...]
Novo Nordisk A/S - share repurchase programme
12/10/2026
Bagsværd, Denmark, 12 October 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR [...]
ANI Pharmaceuticals Announces Positive Phase 4 Open-Label, Single-Arm SYNCHRONICITY Clinical Trial Results Presented as Late Breaking Oral Presentation at the American Academy of Ophthalmology 2026 Annual Meeting
12/10/2026
Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline in CST with statistical significance 1 at 6 months, and these changes were maintained at 24 months (a [...]
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
12/10/2026
ANB033 achieved a statistically significant and clinically meaningful protective effect on both gluten-induced intestinal damage and symptoms LS mean change from baseline in Vh:Cd ratio of -0.17 on ANB033 vs. -0.66 on [...]
Vivani Medical Announces Participation in Upcoming Investor Conferences
12/10/2026
ALAMEDA, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra-long-acting drug implants [...]
Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease
12/10/2026
– Phase 3 INDIGO open-label extension findings demonstrated sustained clinical activity of obexelimab – – Additional analyses of secondary endpoints showed that significantly fewer patients experienced clinically [...]
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth
12/10/2026
The Board of Directors has appointed Peter Anastasiou, former Harmony board member and current Sr. EVP and COO, to become President, Chief Executive Officer and a member of the Board, effective January 1, 2027. Current [...]
Beacon Therapeutics Presents Data from Pivotal VISTA Trial of Laru-zova at AAO 2026
12/10/2026
Late-breaking oral presentation at Retina Subspecialty Day outlines data from Beacon’s pivotal VISTA trial, which met its FDA-endorsed primary endpoint with statistical significance 31.0% of participants in the high [...]
Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
12/10/2026
Study reports sustained IOP reduction and reduced medication burden over 24 months SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based [...]
Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies
12/10/2026
Commercial leader brings lupus nephritis and first-in-class launch experience as FT819 advances in the RECLAIM-LN Phase 2 trial Proven record in advancing breakthrough autoimmune therapies and establishing novel lupus [...]

Pages